Characteristics of the groups of HIV-1–infected patients included in the study
Group . | No. . | Sex . | Last CD4, median (range)* . | Last viral load, median (range)† . | Months on HAART, median (range)‡ . |
---|---|---|---|---|---|
HIV controllers | 55 | M:31 F:24 | 680 (266-1665) | < 40 (< 40-366) | — |
HIV-1 viremics | 9 | M:6 F:3 | 378 (278-654) | 42984 (8048-116 266) | — |
HAART treated | 12 | M:10 F:2 | 633 (292-886) | < 40 (< 40-51) | 45 (7-98) |
Group . | No. . | Sex . | Last CD4, median (range)* . | Last viral load, median (range)† . | Months on HAART, median (range)‡ . |
---|---|---|---|---|---|
HIV controllers | 55 | M:31 F:24 | 680 (266-1665) | < 40 (< 40-366) | — |
HIV-1 viremics | 9 | M:6 F:3 | 378 (278-654) | 42984 (8048-116 266) | — |
HAART treated | 12 | M:10 F:2 | 633 (292-886) | < 40 (< 40-51) | 45 (7-98) |